Common Stock, Shares, Outstanding of AXIM BIOTECHNOLOGIES, INC. from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Axim Biotechnologies, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q2 2024.
  • Axim Biotechnologies, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 294M shares, a 29.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 294M +66.8M +29.3% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 278M +54.8M +24.5% 31 Mar 2024 10-Q/A 22 May 2024
Q4 2023 246M +53.5M +27.8% 31 Dec 2023 10-Q 19 Aug 2024
Q3 2023 238M +99.5M +72.1% 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 228M +89.5M +64.8% 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 224M +72.1M +47.6% 31 Mar 2023 10-Q 22 May 2023
Q4 2022 192M +54.3M +39.4% 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 138M +2.21M +1.63% 30 Sep 2022 10-Q/A 15 Nov 2022
Q2 2022 138M +5.08M +3.82% 30 Jun 2022 10-Q 16 Aug 2022
Q1 2022 152M +24M +18.8% 31 Mar 2022 10-Q 23 May 2022
Q4 2021 138M +12.8M +10.2% 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 136M +10.7M +8.54% 30 Sep 2021 10-Q 22 Nov 2021
Q2 2021 133M +19.9M +17.6% 30 Jun 2021 10-Q 23 Aug 2021
Q1 2021 128M +4.22M +3.42% 31 Mar 2021 10-Q/A 02 Jun 2021
Q4 2020 125M +60.5M +93.2% 31 Dec 2020 10-K/A 19 Apr 2022
Q3 2020 125M +62.4M +99.4% 30 Sep 2020 10-Q/A 27 Nov 2020
Q2 2020 113M +51.3M +83% 30 Jun 2020 10-Q/A 18 Aug 2020
Q1 2020 123M +62.2M +102% 31 Mar 2020 10-Q/A 02 Jul 2020
Q4 2019 64.9M +5.27M +8.85% 31 Dec 2019 10-K/A 26 Apr 2021
Q3 2019 62.8M +4.12M +7.02% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 61.8M +4.3M +7.47% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 61.1M +4.41M +7.78% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 59.6M +5.02M +9.2% 31 Dec 2018 10-K/A 20 May 2020
Q3 2018 58.7M +4.1M +7.52% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 57.5M +4.97M +9.46% 30 Jun 2018 10-Q/A 17 Aug 2018
Q1 2018 56.7M +4.1M +7.8% 31 Mar 2018 10-Q/A 18 May 2018
Q4 2017 54.6M +2.06M +3.92% 31 Dec 2017 10-K 08 Apr 2019
Q3 2017 54.6M +3.07M +5.97% 30 Sep 2017 10-Q 20 Nov 2017
Q2 2017 52.6M +10.8M +25.8% 30 Jun 2017 10-Q/A 14 Sep 2017
Q1 2017 52.6M +12.8M +32.2% 31 Mar 2017 10-Q/A 14 Sep 2017
Q4 2016 52.5M +12.9M +32.5% 31 Dec 2016 10-K 15 Mar 2018
Q3 2016 51.5M +12.1M +30.8% 30 Sep 2016 10-Q/A 30 Nov 2016
Q2 2016 41.8M +2.46M +6.25% 30 Jun 2016 10-Q/A 25 Aug 2016
Q1 2016 39.8M +6.74M +20.4% 31 Mar 2016 10-Q/A 26 May 2016
Q4 2015 39.6M +6.63M +20.1% 31 Dec 2015 10-K/A 14 Sep 2017
Q3 2015 39.4M +6.36M +19.3% 30 Sep 2015 10-Q 23 Nov 2015
Q2 2015 39.3M +6.34M +19.2% 30 Jun 2015 10-Q/A 27 Aug 2015
Q1 2015 33M +18K +0.06% 31 Mar 2015 10-Q 13 May 2015
Q4 2014 33M 0 0% 31 Dec 2014 10-K/A 18 Apr 2016
Q3 2014 33M 0 0% 30 Sep 2014 10-Q 14 Nov 2014
Q2 2014 33M 0 0% 30 Jun 2014 10-Q/A 26 Aug 2014
Q1 2014 33M 0 0% 31 Mar 2014 10-Q/A 18 Jun 2014
Q4 2013 33M 0 0% 31 Dec 2013 10-K 14 Apr 2015
Q3 2013 33M 0 0% 30 Sep 2013 10-Q 18 Nov 2013
Q2 2013 33M 0 0% 30 Jun 2013 10-Q 14 Aug 2013
Q1 2013 33M 0 0% 31 Mar 2013 10-Q 15 May 2013
Q4 2012 33M 0 0% 31 Dec 2012 10-K 04 Mar 2014
Q3 2012 33M 0 0% 30 Sep 2012 10-Q 19 Nov 2012
Q2 2012 33M 30 Jun 2012 10-Q 14 Aug 2012
Q1 2012 33M 31 Mar 2012 10-Q 17 May 2012
Q4 2011 33M +13M +65% 31 Dec 2011 10-K 15 Apr 2013
Q3 2011 33M 30 Sep 2011 10-Q/A 21 Nov 2011
Q4 2010 20M 31 Dec 2010 10-K/A 01 May 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.